Belpointe Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $742K | Sell |
3,361
-2,771
| -45% | -$767K | 0.02% | 585 |
|
|
2026
Q1 | $1.81M | Sell |
6,132
-1,469
| -19% | -$436K | 0.07% | 262 |
|
|
2025
Q4 | $2.08M | Buy |
7,601
+891
| +13% | +$242K | 0.08% | 216 |
|
|
2025
Q3 | $1.81M | Sell |
6,710
-211
| -3% | -$57.4K | 0.07% | 242 |
|
|
2025
Q2 | $1.91M | Buy |
6,921
+134
| +2% | +$36.4K | 0.08% | 213 |
|
|
2025
Q1 | $1.8M | Buy |
6,787
+3,195
| +89% | +$788K | 0.09% | 201 |
|
|
2024
Q4 | $775K | Sell |
3,592
-14
| -0.4% | -$3.22K | 0.05% | 389 |
|
|
2024
Q3 | $796K | Buy |
3,606
+431
| +14% | +$89.2K | 0.05% | 365 |
|
|
2024
Q2 | $624K | Sell |
3,175
-582
| -15% | -$120K | 0.04% | 406 |
|
|
2024
Q1 | $809K | Buy |
3,757
+127
| +3% | +$26.7K | 0.06% | 325 |
|
|
2023
Q4 | $765K | Sell |
3,630
-94
| -3% | -$20.1K | 0.07% | 265 |
|
|
2023
Q3 | $746K | Buy |
3,724
+134
| +4% | +$26.6K | 0.08% | 250 |
|
|
2023
Q2 | $665K | Sell |
3,590
-1,070
| -23% | -$198K | 0.07% | 253 |
|
|
2023
Q1 | $893K | Buy |
4,660
+1,639
| +54% | +$296K | 0.05% | 367 |
|
|
2022
Q4 | $508K | Sell |
3,021
-29
| -1% | -$5.04K | 0.03% | 533 |
|
|
2022
Q3 | $540K | Buy |
3,050
+1,584
| +108% | +$313K | 0.04% | 475 |
|
|
2022
Q2 | $300K | Buy |
1,466
+248
| +20% | +$52.6K | 0.02% | 681 |
|
|
2022
Q1 | $290K | Buy |
1,218
+205
| +20% | +$48.1K | 0.02% | 736 |
|
|
2021
Q4 | $231K | Buy |
1,013
+29
| +3% | +$6.38K | 0.01% | 838 |
|
|
2021
Q3 | $190K | Buy |
984
+174
| +21% | +$35.3K | 0.01% | 878 |
|
|
2021
Q2 | $172K | Buy |
810
+60
| +8% | +$12.7K | 0.01% | 888 |
|
|
2021
Q1 | $153K | Buy |
750
+32
| +4% | +$6.3K | 0.01% | 844 |
|
|
2020
Q4 | $131K | Buy |
718
+19
| +3% | +$3.23K | 0.01% | 847 |
|
|
2020
Q3 | $117K | Sell |
699
-266
| -28% | -$44.8K | 0.01% | 717 |
|
|
2020
Q2 | $157K | Sell |
965
-38
| -4% | -$6.81K | 0.02% | 598 |
|
|
2020
Q1 | $173K | Sell |
1,003
-417
| -29% | -$83K | 0.03% | 456 |
|
|
2019
Q4 | $285K | Sell |
1,420
-288
| -17% | -$59.1K | 0.04% | 451 |
|
|
2019
Q3 | $361K | Buy |
1,708
+237
| +16% | +$49.5K | 0.06% | 356 |
|
|
2019
Q2 | $285K | Sell |
1,471
-129
| -8% | -$23.8K | 0.06% | 336 |
|
|
2019
Q1 | $263K | Sell |
1,600
-1,899
| -54% | -$336K | 0.05% | 263 |
|
|
2018
Q4 | $658K | Buy |
3,499
+1,770
| +102% | +$327K | 0.17% | 133 |
|
|
2018
Q3 | $294K | Buy |
+1,729
| New | +$291K | 0.05% | 365 |
|
|
2018
Q2 | – | Sell |
-5,389
| Closed | -$872K | – | 350 |
|
|
2018
Q1 | $872K | Buy |
5,389
+2,019
| +60% | +$321K | 0.25% | 73 |
|
|
2017
Q4 | $492K | Buy |
3,370
+571
| +20% | +$81.3K | 0.11% | 220 |
|
|
2017
Q3 | $380K | Buy |
+2,799
| New | +$354K | 0.09% | 265 |
|
Other funds holding CME
PAM
SP
RG
GAM
SLAM
HCM
JSSH
CF
Belpointe Asset Management's CME Position: Q2 2026 in Review
Belpointe Asset Management reduced its CME Group (CME) stake by 45% in Q2 2026, selling an estimated $767K and leaving 3,361 shares worth $742K. The position accounts for 0.02% of the portfolio, ranked #585.
Belpointe Asset Management first reported a position in CME in Q3 2017 and has held it in 35 quarters since. The position peaked at $2.08M in Q4 2025. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Belpointe Asset Management held 3,361 shares of CME Group worth $742K as of Q2 2026.
- Belpointe Asset Management sold 2,771 CME Group shares in Q2 2026, an estimated $767K.
- CME Group made up 0.02% of Belpointe Asset Management's portfolio in Q2 2026, its #585 holding.
- Belpointe Asset Management first reported a position in CME Group in Q3 2017 and has held it in 35 quarters since.
- Belpointe Asset Management's CME Group position peaked at $2.08M in Q4 2025.
- 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.